Stock CELATOR PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Celator Pharmaceuticals Inc Stock

Equities

US15089R1023

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Celator Pharmaceuticals Inc
2016 Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal RE
2016 Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ RE
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Latest news about Celator Pharmaceuticals Inc

Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal RE
Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ RE
Steve Cohen’s Point72 says it has perfect U.S. compliance RE
More news

Press releases Celator Pharmaceuticals Inc

Brower Piven Commences An Investigation Into The Proposed Sale Of Celator Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information BU
CELATOR PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Jazz Pharmaceuticals plc BU
Celator Pharmaceuticals : CEO Scott Jackson and President Lawrence Mayer Interviewed by The Life Sciences Report MW
Celator(R) Pharmaceuticals Announces Completion of Its Public Offering and the Exercise in Full of Option to Purchase Additional Units of Common Stock and Warrants to Purchase Common Stock GL
Celator(R) Pharmaceuticals to be Added to Russell MicroCap Index GL
More press releases

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW